There is currently no text in this page. You can search for this page title in other pages, or search the related logs, but you do not have permission to create this page.
Category:CPC C07K16/40
Pages in category "CPC C07K16/40"
The following 79 pages are in this category, out of 79 total.
1
- 18290730. DE-CLUSTERING INHIBITORS OF PTPRA (The Regents of the University of California)
- 18693921. TUMOR-SPECIFIC BISPECIFIC IMMUNE CELL ENGAGER (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18728278. DEVELOPMENT OF NANOBODIES AS FIRST-IN-CLASS INHIBITORS FOR THE DENEDDYLATING ENZYME NEDP1 (Centre National De La Recherche Scientifique)
- 18776496. DISRUPTING TUMOR TISSUES BY TARGETING FIBROBLAST ACTIVATION PROTEIN (FAP) (The Trustees of the University of Pennsylvania)
2
- 20250163182. Enpp3 Cd3 Binding Ag (Janssen Biotech, .)
- 20250163183. Camelid Ant (COAGULANT THERAPEUTICS)
- 20250163184. Methods Compositions Tre (Ashibio, .)
- 20250171559. Method Treating Cancer Using Wrs (KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY)
- 20250171560. Chimeric Antigen Receptor Cells Treating Solid Tum (Innovative Cellular Therapeutics Holdings, .)
- 20250171561. Anti-cd3 (Takeda Pharmaceutical Limited)
- 20250179215. Plasmin-binding Vh (RHEINISCHE FRIEDRICH-WILHELMS-UNIVERSITÄT BONN)
- 20250188188. Antibodies Th (DIANTHUS THERAPEUTICS OPCO, .)
- 20250188189. Human Antib (COAGULANT THERAPEUTICS)
- 20250188190. Utero Treatment Fetus Having (argenx BV)
- 20250188191. Compositions (Fred Hutchison Cancer Center)
- 20250188192. Anti-complement C1s Antibo (Bioverativ USA .)
- 20250206845. Phar (Seoul National University R&DB Foundation)
- 20250230258. Antibody Pre (National Tsing Hua University)
- 20250230259. Androgen Suppression, Prost (CORNELL UNIVERSITY)
- 20250230260. Cdrs Glycos (H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, .)
A
- ACADEMIA SINICA Patent Application Trends in 2025
- Acceleron Pharma Inc. Patent Application Trends in 2025
- Amgen Inc. Patent Application Trends in 2024
- Arizona Board of Regents on behalf of Arizona State University Patent Application Trends in 2024
- ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA Patent Application Trends in 2024
- AstraZeneca AB Patent Application Trends in 2024
B
C
D
G
H
J
- Janssen Biotech, Inc. Patent Application Trends in 2024
- Janssen Biotech, Inc. Patent Application Trends in 2025
- JIANGSU HENGRUI PHARMACEUTICALS CO., LTD. Patent Application Trends in 2024
- JIANGSU HENGRUI PHARMACEUTICALS CO., LTD. Patent Application Trends in 2025
- JIANGSU UNIVERSITY Patent Application Trends in 2025
- Johns Hopkins University Patent Application Trends in 2024
N
S
T
- TAKEDA PHARMACEUTICAL COMPANY LIMITED Patent Application Trends in 2024
- The Board of Trustees of the Leland Stanford Junior University Patent Application Trends in 2024
- THE CHILDREN'S HOSPITAL OF PHILADELPHIA Patent Application Trends in 2025
- The Johns Hopkins University Patent Application Trends in 2024
- The regents of the university of california (20250092156). DE-CLUSTERING INHIBITORS OF PTPRA
- The regents of the university of california (20250145733). TUMOR-SPECIFIC BISPECIFIC IMMUNE CELL ENGAGER
- The Regents of The University Of California Patent Application Trends in 2024
- THE REGENTS OF THE UNIVERSITY OF CALIFORNIA Patent Application Trends in 2024
- The Regents of the University of California Patent Application Trends in 2025
- The Regents of The University Of California Patent Application Trends in 2025
- The Regents of the University of California patent applications on March 20th, 2025
- THE REGENTS OF THE UNIVERSITY OF CALIFORNIA patent applications on May 8th, 2025
- The Regents of the University of Colorado, a Body Corporate Patent Application Trends in 2025
- THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK Patent Application Trends in 2024
- The Trustees of Columbia University in the City of New York Patent Application Trends in 2024
- The University of Toledo Patent Application Trends in 2024
- Trustees of Tufts College Patent Application Trends in 2025